The global Retinal Drugs and Biologics Market is expected to reach USD 46.55 Biliion by the end of 2032, with a valuation of USD 23.29 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 8%. The study examines the factors driving and limiting the global Retinal Drugs and Biologics...